Morgan Stanley lowered the firm’s price target on Comerica (CMA) to $71 from $76 and keeps an Equal Weight rating on the shares. Operating EPS of $1.20 marginally beat the firm’s and consensus estimates, but 2025 expense guidance for growth of 3% missed the Street estimate of 1%, driving stock underperformance after earnings, the analyst tells investors. Net interest income guidance was in-line, but fee guidance was also slightly weaker than expected, the analyst added.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CMA: